Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy

Gandhi Damaj, F. Lefrère, D. Canioni, Marie Thérèse Rubio, I Radford-Weiss, Françoise Valensi, Bruno Varet, Olivier Hermine
In: European Journal of Haematology · 2002 · vol. 68(4) , pp. 233–235 · doi:10.1034/j.1600-0609.2002.01669.x · PMID:12071939 · W2108420098
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

This case report describes a 72-year-old man with myelodysplastic syndrome with myelofibrosis in transformation who achieved remission after danazol therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Danazol has been used with success in some hematological diseases, but there is no report of this treatment in acute leukemia. We report here a case of remission of myelodysplastic syndrome with myelofibrosis in transformation after danazol therapy in a 72-yr-old man. The role of danazol in remission induction is briefly discussed.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (10)

Cited by (2)

Source provenance

openalex
last seen: 2026-05-11T06:24:00.257642+00:00
License: CC0 · commercial use OK